GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Aspira Womens Health Inc (FRA:CUL) » Definitions » PS Ratio

Aspira Womens Health (FRA:CUL) PS Ratio : 2.48 (As of May. 24, 2024)


View and export this data going back to . Start your Free Trial

What is Aspira Womens Health PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Aspira Womens Health's share price is €2.08. Aspira Womens Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.84. Hence, Aspira Womens Health's PS Ratio for today is 2.48.

The historical rank and industry rank for Aspira Womens Health's PS Ratio or its related term are showing as below:

FRA:CUL' s PS Ratio Range Over the Past 10 Years
Min: 2.25   Med: 23.22   Max: 198.48
Current: 2.56

During the past 13 years, Aspira Womens Health's highest PS Ratio was 198.48. The lowest was 2.25. And the median was 23.22.

FRA:CUL's PS Ratio is ranked better than
56.88% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.065 vs FRA:CUL: 2.56

Aspira Womens Health's Revenue per Sharefor the three months ended in Mar. 2024 was €0.17. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.84.

Warning Sign:

Aspira Womens Health Inc revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Aspira Womens Health was -15.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 12.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 9.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was -2.20% per year.

During the past 13 years, Aspira Womens Health's highest 3-Year average Revenue per Share Growth Rate was 130.60% per year. The lowest was -91.30% per year. And the median was 1.20% per year.

Back to Basics: PS Ratio


Aspira Womens Health PS Ratio Historical Data

The historical data trend for Aspira Womens Health's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspira Womens Health PS Ratio Chart

Aspira Womens Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.46 145.24 28.89 4.74 4.12

Aspira Womens Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.09 3.01 5.05 4.12 3.41

Competitive Comparison of Aspira Womens Health's PS Ratio

For the Diagnostics & Research subindustry, Aspira Womens Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspira Womens Health's PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Aspira Womens Health's PS Ratio distribution charts can be found below:

* The bar in red indicates where Aspira Womens Health's PS Ratio falls into.



Aspira Womens Health PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Aspira Womens Health's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=2.08/0.84
=2.48

Aspira Womens Health's Share Price of today is €2.08.
Aspira Womens Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.84.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Aspira Womens Health  (FRA:CUL) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Aspira Womens Health PS Ratio Related Terms

Thank you for viewing the detailed overview of Aspira Womens Health's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aspira Womens Health (FRA:CUL) Business Description

Traded in Other Exchanges
Address
12117 Bee Caves Road, Suite 100, Building 3, Austin, TX, USA, 78738
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. The Company markets and sells, 1) Ova1, a blood test intended as an aid to assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician's independent clinical and radiological evaluation does not indicate malignancy; (2) Overa, a second-generation biomarker reflex intended to maintain Ova1's high sensitivity while improving specificity; (3) Ova1Plus, a reflex offering which uses Ova1 as the primary test and Overa as a confirmation for Ova1 intermediate range results; and (4) OvaWatch, a lab-developed blood test intended to assist in the initial clinical assessment of malignancy risk in all women with an adnexal mass.

Aspira Womens Health (FRA:CUL) Headlines

No Headlines